MTLS — Materialise N.V. stock price, charts and financials

QT75Materialise N.V.

Materialise N.V. (NASDAQ: MTLS) is a Technology company in the Software - Application industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
7.77
+0.06+0.78%
OverviewShort InterestFilings
MTLSQT75Materialise N.V.·NASDAQ
7.77+0.78%
TA
Loading chart...
Signal & projected range
QT Score upgradeHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
UPBD-3.00%$17.13LZ-2.64%$5.91IBTA-0.67%$41.57STRK+7.97%$75.42RDVT-1.53%$75.94GTM-4.98%$3.82DFIN-0.44%$47.81PD-3.05%$14.00
Snapshot
Index-P/E28.78EPS (ttm)0.27Insider Own-Shs Outstand58.56MPerf Week1.70%
Market Cap454.98MForward P/E27.64EPS next Y0.28Insider Trans-Shs Float23.50MPerf Month18.26%
Enterprise Value369.98MPEG-EPS next Q-Inst Own-Short Float0.53%Perf Quarter15.80%
Income15.00MP/S1.41EPS this Y-22.60%Inst Trans-Short Ratio2.84Perf Half Y55.40%
Sales322.00MP/B1.56EPS next Y34.54%ROA3.18%Short Interest312.89KPerf YTD40.00%
Book/sh4.99P/C2.97EPS next 5Y-ROE5.40%52W High7.97 -2.51%Perf Year50.29%
Cash/sh2.61P/FCF22.89EPS past 3/5Y-ROIC2.89%52W Low4.78 62.55%Perf 3Y27.80%
Dividend Est.-EV/EBITDA10.57Sales past 3/5Y5.93% 8.37%Gross Margin57.22%Volatility2.76% 3.63%Perf 5Y-66.88%
Dividend TTM-EV/Sales1.15EPS Y/Y TTM8.51%Oper. Margin3.57%ATR (14)0.25Perf 10Y3.19%
Dividend Ex-Date-Quick Ratio2.22Sales Y/Y TTM11.42%Profit Margin4.83%RSI (14)67.38Recom2.33
Dividend Gr. 3/5Y-Current Ratio2.41EPS Q/Q-SMA206.97%Beta1.33Target Price10.00
Payout0.00%Debt/Eq0.26Sales Q/Q13.70%SMA5012.76%Rel Volume1.34Prev Close7.71
Employees2,556LT Debt/Eq0.22EarningsAug 27SMA20029.15%Avg Volume110.69KPrice7.77
IPO DateJun 25, 2014Option/ShortYes / YesEPS/Sales Surpr.50.80% 0.67%Net Debt/EBITDA-2.43Volume148,691Change0.78%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-20-26ReiteratedCantor Fitzgerald$10
Mar-10-21UpgradeBryan GarnierNeutral → Buy
Apr-07-20DowngradePiper SandlerOverweight → Neutral
Jan-10-20DowngradeKeybancOverweight → Sector Weight
Jul-06-15DowngradeKBC PartnersAccumulate → Hold
Latest News· Times ET
Sep-10-26
Sep-10-2611:34AM
European Equities Traded in the US as American Depositary Receipts Drop in Thursday TradingYahoo
Sep-09-26
Sep-09-2612:01AM
Materialise (NASDAQ:MTLS) Share Price Passes Above 50-Day Moving Average – Time to Sell?defenseworld.net
Sep-04-26
Sep-04-2611:05AM
European Equities Traded in the US as American Depositary Receipts Marginally Higher in Friday TradingYahoo
Aug-31-26
Aug-31-2601:16PM
Materialise: A High-Margin Medical Business Hiding In Plain SightSeekingAlpha
Aug-28-26
Aug-28-2609:02PM
Materialise Q2 Earnings Call Highlightsdefenseworld.net
12:06PM
Materialise To Resume Stock Buyback Plan, Effective Aug. 31Benzinga
Aug-27-26
Aug-27-2607:39AM
Materialise NV (MTLS) Q2 2026 Earnings Call Transcriptseekingalpha.com
06:05AM
Materialise Q2 Earnings Call Highlightsmarketbeat.com
Aug-26-26
Aug-26-2609:00PM
Materialise Reports Second Quarter and Half-Year 2026 Resultsbusinesswire.com
Aug-13-26
Aug-13-2611:00AM
Global 3D Printed Implant Polypropylenes Market Size/Share Worth USD 2.92 Billion by 2035 at a 9.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)Yahoo
02:45AM
Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026businesswire.com
Jul-22-26
Jul-22-2602:26PM
Materialise: Maturing Transition Should Lead To Stronger Performance Going ForwardSeekingAlpha
Jul-01-26
Jul-01-2612:05PM
Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutionsglobenewswire.com
Company

Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue322290289——————
Cost of Goods Sold Incl. D&A137124125——————
Gross Profit183166163——————
Selling, General and Administrative Excl. Other113109110——————
Research and Development575048——————
Other Operating Expense31-5——————
Operating Income11610——————
Interest Expense162——————
Unusual Expense
—————————
Non-Operating Income (Expense)487——————
Net Income Before Taxes16815——————
Income Taxes101——————
Consolidated Net Income15815——————
Net Income From Continuing Operations15815——————
Net Income15815——————
EPS (Recurring)0.270.150.25——————
EPS (Basic, Before Extraordinaries)0.270.150.25——————
EPS (Diluted)0.270.150.25——————
EBITDA352934——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio28.7837.8428.29——————
Price To Sales Ratio1.401.131.44——————
Gross Margin56.8357.2456.40——————
Operating Margin3.422.073.46——————
Net Margin4.662.765.19——————
Shares Outstanding585959——————
Market Capitalization451327415——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.